Results 111 to 120 of about 1,848 (184)

Treatment of Pulmonary Arterial Hypertension in Lithuania: Current Situation and Analysis of Survival of Patients Treated with Different Treatment Regimens. [PDF]

J Clin Med
Miliauskas S, Hoppenot D, Dimiene I, Grigoniene E, Gumbiene L, Nedzelskiene I, Vaizgela M, Ereminiene E.   +7 more
europepmc   +1 more source

Effect of some prostanoid receptor modulators on cholinergic and purinergic pathways in rat model of hemorrhagic cystitis: potential beneficial action of selexipag and alprostadil. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Gerges EM, Helmy MM, Daabees TT, Senbel AM.   +3 more
europepmc   +1 more source

Beyond Vasodilation: Sotatercept and the Dawn of Disease Modification in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. [PDF]

Int J Rheum Dis
Su ST, Wang CY, Shih PC.
europepmc   +1 more source

Comparative efficacy and safety of prostacyclin therapies for pulmonary arterial hypertension: a systematic review and network meta-analysis. [PDF]

Front Med (Lausanne)
Saleh KM, Mallat J, Mohammed S, Bodi G, Alazazzi H, Salim S, Elhennawi M, Iqbal T, Sabbour H.   +8 more
europepmc   +1 more source

A study on the accessibility and utilisation of targeted drugs for pulmonary arterial hypertension in China. [PDF]

Front Pharmacol
Li W, Zhang H, Xu L, Tang W, Lu W, You Z, Wu H, Lin Y, Chen H.   +8 more
europepmc   +1 more source

Start up: A French program to support patients with pulmonary arterial hypertension during the adjustment of prostanoids to the individualized optimal dose. [PDF]

PLoS One
Bergot E, Fertin M, Dewavrin MG, Prévot G, Meijer J, Hakibilen C, Gruand L, Gauthier S, Todea A, Boukerzaza T, Jaïs X.   +10 more
europepmc   +1 more source

Pharmacovigilance assessment of gout: a real-world study using the FAERS database. [PDF]

Front Pharmacol
Ren H, Yao N, Ren X, Su Y, Yao H, Hu J, Wen P, Zhang M, Xu P, Hou W, Yang Z, Yang M.   +11 more
europepmc   +1 more source

Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study. [PDF]

Pulm Circ
Budhram B, Alrasheed SK, Rashad M, Chandy G, Dvorkin-Gheva A, Fox GA, Foxall J, Gardner A, Helmersen D, Hirani N, Kemp K, Kularatne M, Langleben D, Lesenko L, Provencher S, Spence E, Swiston JR, Thakrar M, Wadden D, Weatherald J, Hambly N.   +20 more
europepmc   +1 more source

Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and Ethnicity. [PDF]

J Racial Ethn Health Disparities
Farber HW, Chakinala MM, Hemnes AR, Chin KM, Highland KB, McLaughlin VV, Melendres-Groves LD, Cho M, Doad G, Fatehi E, Han M, Rahman M, Strachan P, Tobore T, Kim NH.   +14 more
europepmc   +1 more source

The Burden of Prior Authorizations for Pediatric Pulmonary Hypertension Medications: A Quantitative Assessment. [PDF]

Pulm Circ
Yung D, Davis A, Merrill K.
europepmc   +1 more source